Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 2 Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Carcinoma, Hepatocellular 27 Parkinson Disease 4, Autosomal Dominant Lewy Body 24 Neoplasms 14 Melanoma 9 Endometrial Neoplasms 8 Carcinoma, Renal Cell 7 Carcinoma, Non-Small-Cell Lung 7 Thyroid Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 6 Cholangiocarcinoma 6 Stomach Neoplasms 4 Recurrence 4 Carcinoma 4 Biliary Tract Neoplasms 4 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Lymphoma 3 Colorectal Neoplasms 3 Triple Negative Breast Neoplasms 2 Paraganglioma, Extra-Adrenal 2 Osteosarcoma 2 Neuroendocrine Tumors 2 Lung Neoplasms 2 Liver Neoplasms 2 Glioma 2 Esophageal Neoplasms 2 Carcinoma, Transitional Cell 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid cancer, Hurthle cell 1

Interventions

Paclitaxel 4 pembrolizumab 2 pazopanib 2 Trastuzumab 2 Sorafenib 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Gefitinib 2 Doxorubicin 2 Cisplatin 2 tumor necrosis factor-alpha, CNGRC fusion protein, human 1 tremelimumab 1 trametinib 1 tipifarnib 1 spartalizumab 1 sargramostim 1 sapanisertib 1 mercaptoundecahydrododecaborate 1 lenvatinib 1 fosbretabulin 1 efatutazone 1 durvalumab 1 dabrafenib 1 crolibulin 1 cabozantinib 1 atezolizumab 1 aldesleukin 1 abemaciclib 1 Taxes 1 Tamoxifen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Thyroid Carcinoma, Anaplastic × lenvatinib × Clear all

NCT02726503 2020-06-17

HOPE

Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

Phase 2 Completed

EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡